Education and Training
Managing Insulin With a Voice AI
This study randomizes participants to have their basal insulin titrated either through standard of care or by receiving prompts through interactions with an AI-enabled smart speaker device. The primary objective of this study is to investigate the feasibility of an AI-enabled smart speaker device and whether such a device facilitates insulin titration management, increases insulin adherence and decreases time to optimal insulin dose. The secondary objective of the study is to explore whether the device improves glycemic control as defined by improvements in fasting blood sugar.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- device: Voice Assistant Device
Eligibility
Inclusion Criteria:
- Patients with Type 2 Diabetes
- Patients clinically indicated to be taking daily long-acting insulin
- Patients currently taking long-acting insulin but necessitating active dose
adjustments
Exclusion Criteria:
- Patients who do not speak English
- Patients who do not own a smart phone
- Patients who do not have stable wireless internet connection at home
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Study Team
650-308-8062
Not Recruiting